[1]
Lee, PharmD, S., Tatla, PharmD, V., Buga, MD, S. and Pon, PharmD, BCOP, BCPS, D. 2022. Comparing the safety and efficacy of intravenous naloxone administration in opioid-naive and opioid-tolerant hospitalized oncology patients. Journal of Opioid Management. 18, 6 (Nov. 2022), 497–502. DOI:https://doi.org/10.5055/jom.2022.0744.